Abstract
NOD1/CARD4 and NOD2/CARD15 are members of Nod-like receptor family. They are located in cytosol, bind bacterial and viral ligands and play a key role in realization of innate and adaptive immune response, apoptosis, autophagy, and reactive oxygen species generation. Polymorphisms in NOD1/CARD4 and NOD2/CARD15 genes may shift balance between pro- and anti-inflammatory cytokines, modulating the risk of infection, chronic inflammation and cancer. According to the data represented in this chapter, NOD1/CARD4 and NOD2/CARD15 gene polymorphisms may be associated with altered risk of gastric, colorectal, breast, ovarian, prostate, testicular, lung, laryngeal, liver, gallbladder, biliary tract, pancreatic, small bowel, kidney, urinary bladder cancer, skin cancer, nonthyroid endocrine tumors, lymphoma and leukemia.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R et al (2001) A frameshift mutation in NOD2 associated with susceptibility to Crohn’s disease. Nature 411:603–606
Hugot JP, Chamaillard M, Zouali H, Lesage S, Cézard JP, Belaiche J et al (2001) Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn’s disease. Nature 411:599–603
Sugimura K, Taylor KD, Lin YC, Hang T, Wang D, Tang YM et al (2003) A novel NOD2/CARD15 haplotype conferring risk for Crohn disease in Ashkenazi Jews. Am J Hum Genet 72:509–518
Andriulli A, Annese V, Latiano A, Palmieri O, Fortina P, Ardizzone S et al (2004) The frame-shift mutation of the NOD2/CARD15 gene is significantly increased in ulcerative colitis: an *IG-IBD study. Gastroenterology 126:625–627
Gazouli M, Mantzaris G, Kotsinas A, Zacharatos P, Papalambros E, Archimandritis A et al (2005) Association between polymorphisms in the Toll-like receptor 4, CD14, and CARD15/NOD2 and inflammatory bowel disease in the Greek population. World J Gastroenterol 11:681–685
Munkholm P (2003) Review article: the incidence and prevalence of colorectal cancer in inflammatory bowel disease. Aliment Pharmacol Ther 18(Suppl 2):1–5
Kurzawski G, Suchy J, Kładny J, Grabowska E, Mierzejewski M, Jakubowska A et al (2004) The NOD2 3020insC mutation and the risk of colorectal cancer. Cancer Res 64:1604–1606
Alhopuro P, Ahvenainen T, Mecklin JP, Juhola M, Järvinen HJ, Karhu A et al (2004) NOD2 3020insC alone is not sufficient for colorectal cancer predisposition. Cancer Res 64:7245–7247
Papaconstantinou I, Theodoropoulos G, Gazouli M, Panoussopoulos D, Mantzaris GJ, Felekouras E et al (2005) Association between mutations in the CARD15/NOD2 gene and colorectal cancer in a Greek population. Int J Cancer 114:433–435
Lubiński J, Huzarski T, Kurzawski G, Suchy J, Masojć B, Mierzejewski M et al (2005) The 3020insC allele of NOD2 predisposes to cancers of multiple organs. Hered Cancer Clin Pract 3:59–63
Roberts RL, Gearry RB, Allington MD, Morrin HR, Robinson BA, Frizelle FA (2006) Caspase recruitment domain-containing protein 15 mutations in patients with colorectal cancer. Cancer Res 66:2532–2535
Irmejs A, Miklasevics E, Boroschenko V, Gardovskis A, Vanags A, Melbarde-Gorkusa I et al (2006) Pilot study on low penetrance breast and colorectal cancer predisposition markers in Latvia. Hered Cancer Clin Pract. 4:48–51
Tuupanen S, Alhopuro P, Mecklin JP, Järvinen H, Aaltonen LA (2007) No evidence for association of NOD2 R702 W and G908R with colorectal cancer. Int J Cancer 121:76–79
Lakatos PL, Hitre E, Szalay F, Zinober K, Fuszek P, Lakatos L et al (2007) Common NOD2/CARD15 variants are not associated with susceptibility or the clinicopathologic characteristics of sporadic colorectal cancer in Hungarian patients. BMC Cancer. 7:54
Suchy J, Kłujszo-Grabowska E, Kładny J, Cybulski C, Wokołorczyk D, Szymańska-Pasternak J et al (2008) Inflammatory response gene polymorphisms and their relationship with colorectal cancer risk. BMC Cancer 8:112
Szeliga J, Sondka Z, Jackowski M, Jarkiewicz-Tretyn J, Tretyn A, Malenczyk M (2008) NOD2/CARD15 polymorphism in patients with rectal cancer. Med Sci Monit 14:CR480–CR484
Möckelmann N, von Schönfels W, Buch S, von Kampen O, Sipos B, Egberts JH et al (2009) Investigation of innate immunity genes CARD4, CARD8 and CARD15 as germline susceptibility factors for colorectal cancer. BMC Gastroenterol 9:79
Tian Y, Li Y, Hu Z, Wang D, Sun X, Ren C (2010) Differential effects of NOD2 polymorphisms on colorectal cancer risk: a meta-analysis. Int J Colorectal Dis 25:161–168
Yazdanyar S, Nordestgaard BG (2010) NOD2/CARD15 genotype and common gastrointestinal diseases in 43,600 individuals. J Intern Med 267:228–236
Freire P, Portela F, Donato MM, Figueiredo P, Ferreira M, Amaro P et al (2010) CARD15 mutations and colorectal cancer in a south European country. Int J Colorectal Dis 25:1211–1219
von Roon AC, Reese G, Teare J, Constantinides V, Darzi AW, Tekkis PP (2007) The risk of cancer in patients with Crohn’s disease. Dis Colon Rectum 50:839–855
Bernstein CN, Blanchard JF, Kliewer E, Wajda A (2001) Cancer risk in patients with inflammatory bowel disease: a population-based study. Cancer 91:854–862
Arnott ID, Nimmo ER, Drummond HE, Fennell J, Smith BR, MacKinlay E et al (2004) NOD2/CARD15, TLR4 and CD14 mutations in Scottish and Irish Crohn’s disease patients: evidence for genetic heterogeneity within Europe? Genes Immun 5:417–425
Rosenstiel P, Hellmig S, Hampe J, Ott S, Till A, Fischbach W et al (2006) Influence of polymorphisms in the NOD1/CARD4 and NOD2/CARD15 genes on the clinical outcome of Helicobacter pylori infection. Cell Microbiol 8:1188–1198
Wex T, Ebert MP, Kropf S, Dierkes J, Schüttler K, Röcken C et al (2008) Gene polymorphisms of the NOD-2/CARD-15 gene and the risk of gastric cancer in Germany. Anticancer Res 28:757–762
Angeletti S, Galluzzo S, Santini D, Ruzzo A, Vincenzi B, Ferraro E et al (2009) NOD2/CARD15 polymorphisms impair innate immunity and increase susceptibility to gastric cancer in an Italian population. Hum Immunol 70:729–732
Hnatyszyn A, Szalata M, Stanczyk J, Cichy W, Slomski R (2010) Association of c.802C > T polymorphism of NOD2/CARD15 gene with the chronic gastritis and predisposition to cancer in H. pylori infected patients. Exp Mol Pathol 88:388–393
Rigoli L, Di Bella C, Fedele F, Procopio V, Amorini M (2010) Lo Giudice G et al. TLR4 and NOD2/CARD15 genetic polymorphisms and their possible role in gastric carcinogenesis. Anticancer Res 30:513–517
Wang P, Zhang L, Jiang JM, Ma D, Tao HX, Yuan SL, Wang YC, Wang LC, Liang H, Zhang ZS, Liu CJ (2012) Association of NOD1 and NOD2 genes polymorphisms with Helicobacter pylori related gastric cancer in a Chinese population. World J Gastroenterol 18:2112–2120
Hemminki K, Li X, Sundquist J, Sundquist K (2009) Cancer risks in Crohn disease patients. Ann Oncol 20:574–580
Forrest MS, Skibola CF, Lightfoot TJ, Bracci PM, Willett EV, Smith MT et al (2006) Polymorphisms in innate immunity genes and risk of non-hodgkin lymphoma. Br J Haematol 134:180–183
Rothman N, Skibola CF, Wang SS, Morgan G, Lan Q, Smith MT et al (2006) Genetic variation in TNF and IL10 and risk of non-hodgkin lymphoma: a report from the interlymph consortium. Lancet Oncol 7:27–38
Türe-Ozdemir F, Gazouli M, Tzivras M, Panagos C, Bovaretos N, Petraki K et al (2008) Association of polymorphisms of NOD2, TLR4 and CD14 genes with susceptibility to gastric mucosa-associated lymphoid tissue lymphoma. Anticancer Res 28:3697–3700
Skibola CF, Bracci PM, Nieters A, Brooks-Wilson A, de Sanjosé S, Hughes AM et al (2010) Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-hodgkin lymphoma in the interlymph consortium. Am J Epidemiol 171:267–276
Huzarski T, Lener M, Domagała W, Gronwald J, Byrski T, Kurzawski G et al (2005) The 3020insC allele of NOD2 predisposes to early-onset breast cancer. Breast Cancer Res Treat 89:91–93
Janiszewska H, Haus O, Lauda-Swieciak A, Bak A, Mierzwa T, Sir J et al (2006) The NOD2 3020insC mutation in women with breast cancer from the Bydgoszcz region in Poland. First results. Hered Cancer Clin Pract 4:15–19
Magnowski P, Medrek K, Magnowska M, Stawicka M, Kedzia H, Górski B et al (2008) The 3020insC NOD2 gene mutation in patients with ovarian cancer. Ginekol Pol 79:544–549
Ashton KA, Proietto A, Otton G, Symonds I, McEvoy M, Attia J et al (2010) Toll-like receptor (TLR) and nucleosome-binding oligomerization domain (NOD) gene polymorphisms and endometrial cancer risk. BMC Cancer 10:382
Nej K, Bartsch DK, Sina-Frey M, Rieder H, Hahn SA, Lubiński J (2004) The NOD2 3020insC mutation and the risk of familial pancreatic cancer? Hered Cancer Clin Pract 2:149–150
Debniak T, Kurzawski G, Huzarski T, Byrski T, Gronwald J, Debniak B et al (2005) NOD2 variants and the risk of malignant melanoma. Eur J Cancer Prev 14:143–146
Ennas MG, Moore PS, Zucca M, Angelucci E, Cabras MG, Melis M et al (2008) Interleukin-1B (IL1B) and interleukin-6 (IL6) gene polymorphisms are associated with risk of chronic lymphocytic leukaemia. Hematol Oncol 26:98–103
McGovern DP, Hysi P, Ahmad T, van Heel DA, Moffatt MF, Carey A et al (2005) Association between a complex insertion/deletion polymorphism in NOD1 (CARD4) and susceptibility to inflammatory bowel disease. Hum Mol Genet 14:1245–1250
Tanabe T, Ishige I, Suzuki Y, Aita Y, Furukawa A, Ishige Y et al (2006) Sarcoidosis and NOD1 variation with impaired recognition of intracellular Propionibacterium acnes. Biochim Biophys Acta 1762:794–801
Boffetta P, Rabkin CS, Gridley G (2009) A cohort study of cancer among sarcoidosis patients. Int J Cancer 124:2697–2700
Ji J, Shu X, Li X, Sundquist K, Sundquist J, Hemminki K (2009) Cancer risk in hospitalized sarcoidosis patients: a follow-up study in Sweden. Ann Oncol 20:1121–1126
Hofner P, Gyulai Z, Kiss ZF, Tiszai A, Tiszlavicz L, Tóth G et al (2007) Genetic polymorphisms of NOD1 and IL-8, but not polymorphisms of TLR4 genes, are associated with Helicobacter pylori-induced duodenal ulcer and gastritis. Helicobacter 12:124–131
Kara B, Akkiz H, Doran F, Bayram S, Erken E, Gumurdullu Y et al (2010) The significance of E266 K polymorphism in the NOD1 gene on Helicobacter pylori infection: an effective force on pathogenesis? Clin Exp Med. 10:107–112
Molnar T, Hofner P, Nagy F, Lakatos PL, Fischer S, Lakatos L et al (2007) NOD1 gene E266 K polymorphism is associated with disease susceptibility but not with disease phenotype or NOD2/CARD15 in Hungarian patients with Crohn’s disease. Dig Liver Dis 39:1064–1070
Verma R, Ahuja V, Paul J (2009) Frequency of single nucleotide polymorphisms in NOD1 gene of ulcerative colitis patients: a case-control study in the Indian population. BMC Med Genet 10:82
Huebner C, Ferguson LR, Han DY, Philpott M, Barclay ML, Gearry RB et al (2009) Nucleotide-binding oligomerization domain containing 1 (NOD1) haplotypes and single nucleotide polymorphisms modify susceptibility to inflammatory bowel diseases in a New Zealand caucasian population: a case-control study. BMC Res Notes 2:52
Kupcinskas J, Wex T, Bornschein J, Selgrad M, Leja M, Juozaityte E, Kiudelis G, Jonaitis L, Malfertheiner P (2011) Lack of association between gene polymorphisms of Angiotensin converting enzyme, Nod-like receptor 1, Toll-like receptor 4, FAS/FASL and the presence of Helicobacter pylori-induced premalignant gastric lesions and gastric cancer in caucasians. BMC Med Genet 12:112
Wu CY, Hu HY, Pu CY, Huang N, Shen HC, Li CP et al (2011) Pulmonary tuberculosis increases the risk of lung cancer: a population-based cohort study. Cancer 117:618–624
Shiels MS, Albanes D, Virtamo J, Engels EA (2011) Increased risk of lung cancer in men with tuberculosis in the alpha-tocopherol, beta-carotene cancer prevention study. Cancer Epidemiol Biomarkers Prev 20:672–678
Shebl FM, Engels EA, Goedert JJ, Chaturvedi AK (2010) Pulmonary infections and risk of lung cancer among persons with AIDS. J Acquir Immune Defic Syndr 55:375–379
Kocazeybek B (2003) Chronic Chlamydophila pneumoniae infection in lung cancer, a risk factor: a case-control study. J Med Microbiol 52:721–726
Austin CM, Ma X, Graviss EA (2008) Common nonsynonymous polymorphisms in the NOD2 gene are associated with resistance or susceptibility to tuberculosis disease in African, Americans. J Infect Dis 197:1713–1716
Leung E, Hong J, Fraser AG, Merriman TR, Vishnu P, Abbott WG et al (2005) Polymorphisms of CARD15/NOD2 and CD14 genes in New Zealand Crohn’s disease patients. Immunol Cell Biol 83:498–503
Gearry RB, Roberts RL, Burt MJ, Frampton CM, Chapman BA, Collett JA et al (2007) Effect of inflammatory bowel disease classification changes on NOD2 genotype-phenotype associations in a population-based cohort. Inflamm Bowel Dis 13:1220–1227
Heliö T, Halme L, Lappalainen M, Fodstad H, Paavola-Sakki P, Turunen U et al (2003) CARD15/NOD2 gene variants are associated with familially occurring and complicated forms of Crohn’s disease. Gut 52:558–562
Lappalainen M, Paavola-Sakki P, Halme L, Turunen U, Färkkilä M, Repo H et al (2008) Novel CARD15/NOD2 mutations in Finnish patients with Crohn’s disease and their relation to phenotypic variation in vitro and in vivo. Inflamm Bowel Dis 14:176–185
Bene J, Magyari L, Talián G, Komlósi K, Gasztonyi B, Tari B et al (2006) Prevalence of SLC22A4, SLC22A5 and CARD15 gene mutations in Hungarian pediatric patients with Crohn’s disease. World J Gastroenterol 12:5550–5553
Büning C, Molnar T, Nagy F, Lonovics J, Weltrich R, Bochow B et al (2005) NOD2/CARD15 gene polymorphism in patients with inflammatory bowel disease: is Hungary different? World J Gastroenterol 11:407–411
Csöngei V, Járomi L, Sáfrány E, Sipeky C, Magyari L, Faragó B et al (2010) Interaction of the major inflammatory bowel disease susceptibility alleles in Crohn’s disease patients. World J Gastroenterol 16:176–183
Lakatos PL, Lakatos L, Szalay F, Willheim-Polli C, Osterreicher C, Tulassay Z et al (2005) Toll-like receptor 4 and NOD2/CARD15 mutations in Hungarian patients with Crohn’s disease: phenotype-genotype correlations. World J Gastroenterol 11:1489–1495
Nagy Z, Karádi O, Rumi G, Rumi G Jr, Pár A, Mózsik G et al (2005) Crohn’s disease is associated with polymorphism of CARD15/NOD2 gene in a Hungarian population. Ann NY Acad Sci 1051:45–51
Medici V, Mascheretti S, Croucher PJ, Stoll M, Hampe J, Grebe J et al (2006) Extreme heterogeneity in CARD15 and DLG5 Crohn disease-associated polymorphisms between German and Norwegian populations. Eur J Hum Genet 14:459–468
Radlmayr M, Torok HP, Martin K, Folwaczny C (2002) The cinsertion mutation of the NOD2 gene is associated with fistulizing and fibrostenotic phenotypes in Crohn’s disease. Gastroenterology 122:2091–2092
Büning C, Genschel J, Bühner S, Krüger S, Kling K, Dignass A et al (2004) Mutations in the NOD2/CARD15 gene in Crohn’s disease are associated with ileocecal resection and are a risk factor for reoperation. Aliment Pharmacol Ther 19:1073–1078
Buhner S, Buning C, Genschel J, Kling K, Herrmann D, Dignass A et al (2006) Genetic basis for increased intestinal permeability in families with Crohn’s disease: role of CARD15 3020insC mutation? Gut 55:342–347
Vind I, Vieira A, Hougs L, Tavares L, Riis L, Andersen PS et al (2005) NOD2/CARD15 gene polymorphisms in Crohn’s disease: a genotype-phenotype analysis in Danish and Portuguese patients and controls. Digestion 72:156–163
Ferreira AC, Almeida S, Tavares M, Canedo P, Pereira F, Regalo G et al (2005) NOD2/CARD15 and TNFA, but not IL1B and IL1RN, are associated with Crohn’s disease. Inflamm Bowel Dis 11:331–339
Gazouli M, Pachoula I, Panayotou I, Mantzaris G, Chrousos G, Anagnou NP et al (2010) NOD2/CARD15, ATG16L1 and IL23R gene polymorphisms and childhood-onset of Crohn’s disease. World J Gastroenterol 16:1753–1758
Gazouli M, Zacharatos P, Mantzaris GJ, Barbatis C, Ikonomopoulos I, Archimandritis AJ et al (2004) Association of NOD2/CARD15 variants with Crohn’s disease in a Greek population. Eur J Gastroenterol Hepatol 16:1177–1182
Gaj P, Habior A, Mikula M, Ostrowski J (2008) Lack of evidence for association of primary sclerosing cholangitis and primary biliary cirrhosis with risk alleles for Crohn’s disease in Polish patients. BMC Med Genet 9:81
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2013 Springer Basel
About this chapter
Cite this chapter
Kutikhin, A.G., Yuzhalin, A.E. (2013). Structural Genomic Variation in NOD-Like Receptors and Cancer. In: Genomics of Pattern Recognition Receptors. Springer, Basel. https://doi.org/10.1007/978-3-0348-0688-6_7
Download citation
DOI: https://doi.org/10.1007/978-3-0348-0688-6_7
Published:
Publisher Name: Springer, Basel
Print ISBN: 978-3-0348-0687-9
Online ISBN: 978-3-0348-0688-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)